T1	Participants 13 81	recurrent or persistent nasopharyngeal carcinomas after radiotherapy
T2	Participants 478 531	recurrent or residual nasopharyngeal carcinomas (NPC)
T3	Participants 537 551	benign lesions
T4	Participants 669 692	Thirty six NPC patients
T5	Participants 796 821	recurrent or residual NPC
